Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 1;4(11):e2133877.
doi: 10.1001/jamanetworkopen.2021.33877.

Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages

Affiliations

Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages

Elad Neeman et al. JAMA Netw Open. .

Abstract

Importance: Telehealth use including secure messages has rapidly expanded since the COVID-19 pandemic, including for multidisciplinary aspects of cancer care. Recent reports described rapid uptake and various benefits for patients and clinicians, suggesting that telehealth may be in standard use after the pandemic.

Objective: To examine attitudes and perceptions of multidisciplinary cancer care clinicians toward telehealth and secure messages.

Design, setting, and participants: Cross-sectional specialty-specific survey (ie, some questions appear only for relevant specialties) among multidisciplinary cancer care clinicians, collected from April 29, 2020, to June 5, 2020. Participants were all 285 clinicians in the fields of medical oncology, radiation oncology, surgical oncology, survivorship, and oncology navigation from all 21 community cancer centers of Kaiser Permanente Northern California.

Main outcomes and measures: Clinician satisfaction, perceived benefits and challenges of telehealth, perceived quality of telehealth and secure messaging, preferred visit and communication types for different clinical activities, and preferences regarding postpandemic telehealth use.

Results: A total of 202 clinicians (71%) responded (104 of 128 medical oncologists, 34 of 37 radiation oncologists, 16 of 62 breast surgeons, 18 of 28 navigators, and 30 of 30 survivorship experts; 57% (116 of 202) were women; 73% [147 of 202] between ages 36-55 years). Seventy-six percent (n = 154) were satisfied with telehealth without statistically significant variations based on clinician characteristics. In-person visits were thought to promote a strong patient-clinician connection by 99% (n = 137) of respondents compared with 77% (n = 106) for video visits, 43% (n = 59) for telephone, and 14% (n = 19) for secure messages. The most commonly cited benefits of telehealth to clinicians included reduced commute (79%; n = 160), working from home (74%; n = 149), and staying on time (65%; n = 132); the most commonly cited negative factors included internet connection (84%; n = 170) or equipment problems (72%; n = 146), or physical examination needed (64%; n = 131). Most respondents (59%; n = 120) thought that video is adequate to manage the greater part of patient care in general; and most deemed various telehealth modalities suitable for any of the queried types of patient-clinician activities. For some specific activities, less than half of respondents thought that only an in-person visit is acceptable (eg, 49%; n = 66 for end-of-life discussion, 35%; n = 58 for new diagnosis). Most clinicians (82%; n = 166) preferred to maintain or increase use of telehealth after the pandemic.

Conclusions and relevance: In this survey of multidisciplinary cancer care clinicians in the COVID-19 era, telehealth was well received and often preferred by most cancer care clinicians, who deemed it appropriate to manage most aspects of cancer care. As telehealth use becomes routine in some cancer care settings, video and telephone visits and use of asynchronous secure messaging with patients in cancer care has clear potential to extend beyond the pandemic period.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Kumar reported that her father owns a telehealth company. Dr Trosman reported receiving other funding from Genentech Consulting outside the submitted work. Dr Weldon reported receiving grants from the Coleman Foundation, which did not directly fund this work but did fund some work conducted with the UIC during the conduct of the study; personal fees from Genentech not specific to published work, grants from Merck Foundation not specific to published work, grants from Pfizer Foundation not specific to published work, personal fees from ECOG-ACRIN not specific to published work, personal fees from NCCN not specific to published work, personal fees from ACCC not specific to published work, and personal fees from Lungevity not specific to published work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Clinician Satisfaction Levels With Telehealth
Figure 2.
Figure 2.. Clinician Perceptions of Benefits and Challenges With Telehealth
Figure 3.
Figure 3.. Encounter Types Deemed Most Appropriate by Clinicians for Various Cancer Care Related Activities

References

    1. Royce TJ, Sanoff HK, Rewari A. Telemedicine for cancer care in the time of COVID-19. JAMA Oncol. 2020;6(11):1698-1699. doi:10.1001/jamaoncol.2020.2684 - DOI - PMC - PubMed
    1. Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book. 2018;38:540-545. doi:10.1200/EDBK_200141 - DOI - PubMed
    1. Heyer A, Granberg RE, Rising KL, Binder AF, Gentsch AT, Handley NR. Medical oncology professionals’ perceptions of telehealth video visits. JAMA Netw Open. 2021;4(1):e2033967. doi:10.1001/jamanetworkopen.2020.33967 - DOI - PMC - PubMed
    1. Reed ME, Parikh R, Huang J, Ballard DW, Barr I, Wargon C. Real-time patient-provider video telemedicine integrated with clinical care. N Engl J Med. 2018;379(15):1478-1479. doi:10.1056/NEJMc1805746 - DOI - PubMed
    1. Liu R, Sundaresan T, Reed ME, Trosman JR, Weldon CB, Kolevska T. Telehealth in oncology during the COVID-19 outbreak: bringing the house call back virtually. JCO Oncol Pract. 2020;16(6):289-293. doi:10.1200/OP.20.00199 - DOI - PubMed

Publication types